The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.70
Bid: 32.00
Ask: 33.40
Change: -0.40 (-1.21%)
Spread: 1.40 (4.375%)
Open: 33.10
High: 33.20
Low: 32.70
Prev. Close: 33.10
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) Merchant Securities Group Plc

5 Oct 2011 18:31

RNS Number : 6562P
Merchant Securities Group PLC
05 October 2011
 



 

 

This announcement replaces the announcement released at 17.34 on 09 September 2011 under RNS reference number 0080O. Due to an administrative error, the shareholding attributed to **MSL Discretionary Clients Holdings in Section 3 as a person acting on concert, was incorrectly stated. The correct opening position disclosure is now included. All other details remain unchanged.

 

 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the party to the offer making the disclosure:

Merchant Securities Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each party to the offer

Merchant Securities Group plc ("MSG plc")

(d) Is the party to the offer making the disclosure the offeror or the offeree?

OFFEREE

(e) Date position held:

05 September 2011

(f) Has the party previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

1 penny ordinary shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0

0

0

(2) Derivatives (other than options):

0

0

0

0

(3) Options and agreements to purchase/sell:

0

0

0

0

 

TOTAL:

0

0

0

0

 

 

Class of relevant security:

 

Warrants

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0

0

0

(2) Derivatives (other than options):

0

0

0

0

(3) Options and agreements to purchase/sell:

0

0

0

0

 

TOTAL:

0

0

0

0

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(c) Irrevocable commitments and letters of intent

 

Details of any irrevocable commitments or letters of intent procured by the party to the offer making the disclosure or any person acting in concert with it (see Note 3 on Rule 2.11 of the Code):

None

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe of any person acting in concert with the party to the offer making the disclosure:

Name

 

Number of Ordinary 1p Shares interested in

 

%

 

 

 

Directors MSG plc:

Patrick Claridge

John East

John Foster-Powell

*John Green

Charles Price

 

Directors MSL:

*David Worlidge

Simon Clements

Graeme Smith

Paul Chapman

 

Directors MSWM:

\* Tim Wall

Wayne Ellis

 

 

Employee Benefit Trust:

 

 

 

**MSL Discretionary Clients Holdings:

 

 2,563,028

4,495,000

600,000

125,431

416,009

 

 

2,748,572

 517,857

74,630

40,000

 

 

4,130,435

100,833

 

 

1,350,000

 

 

 

 

 

 425,000

 

4.99

8.75

1.17

0.24

0.81

 

 

5.35

 1.00

0.15

0.08

 

 

8.04

0.20

 

 

2.63

 

 

 

 

 

 0.83

 

*includes 928,572 shares for David Worlidge, 173,912 shares for Tim Wall and 82,574 shares for John Green held by their close relatives.

**includes 85,000 shares for Patrick Claridge and 225,000 shares for Simon Clements, managed under a discretionary mandate by MSL, which are not included in their individual holdings above as they are not able to exercise the votes on these shares at a general meeting of the Company.

Name

 

Number of Warrants interested in

 

Exercise Price

 

Expiry Date

 

 

0

 

0

 

 

0

 

 

0

 

Name

Options to purchase shares

Exercise Price

Expiry Date

Directors MSG plc:

Patrick Claridge

Patrick Claridge

John Foster-Powell

John Green

Charles Price

 

Directors MSL:

Simon Clements

Simon Clements

Graeme Smith

Paul Chapman

 

Directors MSWM:

Wayne Ellis

Wayne Ellis

 

 

562,514

550,000

400,000

100,203

66,802

 

 

214,286

400,000

243,600

100,000

 

 

150,000

300,000

 

£0.10

£0.30

£0.10

£0.10

£0.10

 

 

£0.10

£0.30

£0.10

£0.10

 

 

£0.10

£0.30

 

08-Sep-19

22-Jul-20

08-Sep-19

08-Sep-19

08-Sep-19

 

 

08-Sep-19

22-Jul-20

08-Sep-19

08-Sep-19

 

 

08-Sep-19

22-Jul-20

 

Options expiring on 08-Sep-19 are subject to a vesting schedule whereby one third of the award vests on grant (09-Sep-09) and the balance of the award vests in three equal instalments on the first, second and third anniversaries of the grant. Options expiring on 22-Jul-20 vest in three equal instalments on the first, second and third anniversaries of the grant (23-Jul-10). In the event of a general offer to acquire the whole of the issued ordinary share capital of the company, all Options may be exercised following the announcement of a firm intention to make an offer, conditional on completion of the offer.

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3 for each additional class of relevant security.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

05 October 2011

Contact name:

Paul Chapman (Merchant Securities)

Telephone number:

0207 375 9051

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEUVUBRAWARRAA
Date   Source Headline
1st Dec 20207:00 amRNSInterim Results
27th Nov 20207:00 amRNSInvestor Presentation
6th Nov 20207:00 amRNSNotice of Results and Investor Presentations
3rd Nov 20207:00 amRNSBoard Appointment
30th Oct 20207:30 amRNSNew direct investment into Sense Biodetection
19th Oct 20207:00 amRNSSuccessful exit of Clear Review
7th Oct 20207:00 amRNSWarwick Acoustics Update
25th Sep 20207:00 amRNSDirector/PDMR Dealings
24th Sep 202010:29 amRNSResult of AGM
24th Sep 20207:00 amRNSAGM Statement
18th Sep 20207:00 amRNSLife Sciences’ Portfolio Update
24th Aug 20207:00 amRNSGrant of Options
31st Jul 20207:03 amRNSPublication of Annual Report
29th Jul 20202:31 pmRNSDirector/PDMR Dealings
14th Jul 20207:00 amRNSPreliminary results
9th Jul 20207:00 amRNSSale of The Native Antigen Company
1st Jul 20207:00 amRNSPortfolio company MIP Diagnostics raises £5.1m
11th Jun 20207:00 amRNSNotice of Results
27th May 202011:08 amRNSMercia accredited by BBB under CBILS
14th May 20207:00 amRNSMedherant partners with Cycle Pharmaceuticals
6th May 20207:00 amRNSInvestment into OXGENE
21st Apr 20207:00 amRNSBritish Business Bank increases Mercia’s mandate
3rd Apr 202012:47 pmRNSNVM VCTs raise £38.2 million
2nd Apr 20207:00 amRNSPortfolio companies collaborate against COVID-19
27th Mar 202011:30 amRNSDirector/PDMR Dealings
25th Mar 20203:08 pmRNSCOVID-19 Business Update
25th Mar 20201:42 pmRNSNotification of Major Holdings
18th Mar 202010:59 amRNSNOTIFICATION OF MAJOR HOLDINGS
11th Mar 20204:18 pmRNSNOTIFICATION OF MAJOR HOLDINGS
4th Feb 20203:20 pmRNSNOTIFICATION OF MAJOR HOLDINGS
4th Feb 20203:20 pmRNSPDMR / Director Dealings
4th Feb 20208:50 amRNSNotification of Major Holdings
4th Feb 20207:00 amRNSHolding in Company
29th Jan 20207:00 amRNSGrant of Options
22nd Jan 202012:49 pmRNSForm 8.3 - RedX Pharma PLC
17th Jan 20204:45 pmRNSNotification of Major Holdings
16th Jan 20207:00 amRNSnDreams makes continuing commercial progress
9th Jan 20202:06 pmRNSNOTIFICATION OF MAJOR HOLDINGS
9th Jan 20202:00 pmRNSNOTIFICATION OF MAJOR HOLDINGS
31st Dec 201910:55 amRNSNotification of Major Holdings
30th Dec 201911:57 amRNSNOTIFICATION OF MAJOR HOLDINGS
30th Dec 201911:36 amRNSNOTIFICATION OF MAJOR HOLDINGS
27th Dec 201912:01 pmRNSNOTIFICATION OF MAJOR HOLDINGS
24th Dec 201912:16 pmRNSNOTIFICATION OF MAJOR HOLDINGS
23rd Dec 20193:36 pmRNSNOTIFICATION OF MAJOR HOLDINGS
23rd Dec 20192:14 pmRNSNOTIFICATION OF MAJOR HOLDINGS
23rd Dec 20192:04 pmRNSCompletion of Acquisition
23rd Dec 201912:44 pmRNSNOTIFICATION OF MAJOR HOLDINGS
23rd Dec 20199:49 amRNSDirector/PDMR Dealings
20th Dec 201910:29 amRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.